Advancing type 2 diabetes therapy with iGlarLixi in older people: Pooled analysis of four randomized controlled trials
Munshi M, Ritzel R, Jude EB, et al.
Diabetes Obes Metab. Pub. online 11 Dec 2023.
Leggi
Translating trial results into interpretable risk estimates: systematic analysis of cardiorenal outcome trials of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors
Rizzi A, Kloecker DE, Pitocco D, et al.
NMCD. Pub. online 19 Dec 2023.
Leggi
Linee di indirizzo AMD-SID sulla nutrizione nella gravidanza fisiologica o complicata da obesità e/o diabete
Leggi
Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial
Wu J, Zhou R, Zhang Q, et al.
Diabetes Obes Metab. Pub. online 15 Dec 2023.
Leggi
A novel model for predicting diabetes remission after bariatric surgery based on the measurement of C-peptide and creatinine in serum: a pilot study
Colosimo S, Martínez-Sánchez MA, Balaguer-Román A, et al.
NMCD. Pub. online, 16 Dec 2023.
Leggi
Bando Horizon Europe – Work Programme 2023 – Health
Carissimi Soci, siamo lieti di condividere questa nuova opportunità derivante dalla partecipazione di AMD al Bando Horizon Europe – Work Programme 2023 - Health con il progetto “dAIbetes - Federated virtual twins for privacy-preserving personalised outcome prediction of type 2 diabetes treatment”. Grazie al database Annali e alla collaborazione con la Sapienza…
Leggi
Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy
Cesta CE, Rotem R, Bateman BT, et al.
JAMA Intern Med. 2023:e236663.
Leggi
Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial
Aronne LJ, Sattar N, Horn DB, et al.
JAMA. 2023:e2324945.
Leggi
Incretin‐based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta‐analysis of observational studies
Igweokpala S, Sule NO, Douros A, et al.
Diabetes Obes Metab. Pub. online 29 Nov 2023.
Leggi
Child-to-adult body size change and risk of type 2 diabetes and cardiovascular disease
Carrasquilla GD, Ängquist L, Sørensen TIA, et al.
Diabetologia. Pub. online 12 Dec 2023.
Leggi